Friday, September 30, 2022


Biotechnology News Magazine

Thermo Fisher Scientific Reports New Non-Hazardous Viral Inactivation Medium

Supports Safe Collection and Transport of SARS-CoV-2

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Thermo Scientific reports a new viral transport medium that enables collection and rapid inactivation of the SARS-CoV-2 virus, and stabilizes viral RNA at ambient temperature for transportation and use in in vitro diagnostic testing procedures, is now available in Europe.

Thermo Fisher Scientific developed the InhibiSURE Viral Inactivation Medium formula to be non-hazardous. Other inactivation media typically rely on a formulation that is potentially hazardous to inactivate viruses. Many contain a guanidine-based chemical that, if mixed with bleach or strong acids, could release toxic cyanide gas. The use of inactivation medium also removes the need for further inactivation steps, increasing laboratory throughput.

This single-use device, for professional use only, can be used for sampling patients that are suspected of being infected with SARS-CoV-2 or sampling individuals for population screening for SARS-CoV-2.

“As testing demands continue to change dynamically throughout this pandemic, we remain committed to keeping laboratorians safe and protected during the testing process,” said Duncan Porter, general manager, sample collection and transport for Thermo Fisher’s microbiology business. The InhibiSURE Viral Inactivation Medium enables us to support a safe and efficient sample collection and transport process by rapidly inactivating the SARS-CoV-2 virus using a non-hazardous formulation. To broaden the scope of those capabilities, we’ve prioritized the expansion of the range of viruses, as well as the ability to do at-home collection as future developments.”

InhibiSURE Viral Inactivation Medium:

  • Helps keep staff safe, inactivating SARS-CoV-2 within 30 minutes of sampling with a non-hazardous formula that does not contain any products that may react with bleach
  • Provides a convenient, leakproof, format that can be used with unprocessed nasal swabs, nasopharyngeal swabs or throat swabs on automation preparation racks and decappers
  • Enhances simplicity by removing the need for de-activation steps, and is suitable for use with bead and column-based PCR systems

InhibiSURE Viral Inactivation Medium is now commercially available from Thermo Fisher Scientific in Europe, with plans for launch in other regions pending relevant regulatory approvals. For more information, visit

Product is CE marked but not 510(k)-cleared and not available for sale in the U.S. Availability of product in each country depends on local regulatory marketing authorization status.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine